Explained: Challenge Of An Overwhelmed Healthcare System Stares At China As It Eases COVID Restrictions
The protests in China have forced the Chinese government to gradually relax its epidemic prevention and control measures, but whether the authorities are ready to "fully open up" is causing concern in China and in the outside world. Are Chinese policy makers learning from the process of other countries opening up? What are the risks China is facing?
China's State Council announced ten measures to relax epidemic prevention on December 7. After many days of large-scale "white paper movement" protests, China is the last major country to open up. There is a wide range of speculation about why China maintained harsh lockdown measures for so long and the most credible one of them is that China’s vaccines are simply not effective enough.
Avril Haines, director of national intelligence of the US, recently said in an interview that Xi Jinping does not want to take western vaccines despite knowing that Chinese vaccines are less effective. The director of national intelligence has access to extraordinary amount of classified information and if she is publicly making such a statement, than it is highly likely that the reason Beijing was maintaining harsh restrictions, is because the regime was concerned about deaths and wanted to prevent them.
People in China still have differences in their views on comprehensive opening up. There are many aged people who are not vaccinated at all, mostly in urban areas and many of them don’t want to get vaccinated.
China has been following the path of lockdowns for too long and it has developed path dependency. It is unclear if they know how to conduct a full opening as the opening up was not really planned and the Chinese regime just did to alleviate the widespread unrest in China.
Two years ago, many countries in Europe and the United States were also facing the dilemma of sealing and unblocking the epidemic. When the COVID-19 outbreak broke out in early 2020, the then President of the United States, Donald Trump, declared a national emergency. At the same time, with the increase in the number of confirmed cases and deaths, and the shortage of medical protection supplies, offices, schools, restaurants, etc. successively closed.
At the same time, European countries have also faced more severe challenges. In the early days of the outbreak, there were more than 10,000 confirmed cases in Europe every day. Many countries entered a state of blockade, social gatherings were banned, and many entertainment venues were closed. The only reason for people to leave home was to go to work, buy daily necessities, and seek medical treatment or exercise for an hour a day. It is worth noting that even under the “blockade", people in Western countries could still go out, and had not been forced to be quarantined by the government due to confirmed diagnoses and close contacts.
Even Japan and Taiwan, which have extremely strict epidemic prevention policies, have gradually relaxed their epidemic prevention measures recently. Inbound passengers no longer need to be quarantined, and no negative nucleic acid certificates are required.
Analysts believe that the risk of an epidemic is significant. The fear is that China’s healthcare system will be overwhelmed. The policy of treating mild patients in home and limiting the hospitalisation of severe patients is aimed to optimise the medical resources available.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.